Results for tag: "Hyperkalemia Drug"

Hyperkalemia is a condition in which the level of potassium in the blood is abnormally high. Hematological drugs are used to treat this condition, as they can help to reduce the amount of potassium in the blood. These drugs work by blocking the reabsorption of potassium in the kidneys, allowing it to be excreted in the urine. Commonly used hematological drugs for hyperkalemia include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and diuretics. These drugs can be used alone or in combination with other medications to reduce the amount of potassium in the blood. The hyperkalemia drug market is a rapidly growing sector of the pharmaceutical industry. It is driven by the increasing prevalence of hyperkalemia, as well as the development of new drugs and treatments. Companies in this market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. Show Less Read more